MedTrace Logo

RCT Superior Hypogastric Block During LH

NCT03283436 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-10-27

Study results available
· View outcomes & findings →

Summary

The goal of this study is to assess the efficacy of a superior hypogastric plexus block (SHPB) for pain relief following a laparoscopic hysterectomy.

Conditions

  • Hysterectomy

Interventions

DRUG

Bupivacaine Hydrochloride 0.25% Injection Solution

10 mL of 0.25% bupivacaine hydrochloride (2.5 mg/mL = 25 mg)

Sponsors & Collaborators

  • University of North Carolina

    collaborator OTHER

  • George Washington University

    collaborator OTHER

  • Jon I. Einarsson

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2019-02-21
Completion
2019-02-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03283436 on ClinicalTrials.gov